Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SMH vs GSK✓SelectedUSD · GSKSMH vs GSK performance historyLatest closeAs of-0.12%11/18
Stock and ETF performance explorer

SMH vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+205.3%
GSK return
+42.7%
Excess return
+162.7%
Maximum drawdown
-45.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.1%-1.3%+1.2%0.0%
7D-9.4%-3.1%-6.2%-9.1%
30D-16.2%-0.9%-15.3%-16.2%
3M-19.3%-4.2%-15.2%-19.1%
6M-15.9%-1.6%-14.3%-16.1%
YTD+27.6%+2.6%+25.0%+26.2%
1Y+38.3%+6.2%+32.1%+36.1%
3Y+186.5%+55.0%+131.6%+158.4%
5Y+205.3%+42.8%+162.5%+151.9%
All+205.3%+42.7%+162.7%+151.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling